Infectious Diseases

Combination treatment reduces mortality in hospitalized patients with MERS

A combination of recombinant interferon beta-1b and lopinavir–ritonavir reduced mortality in patients with Middle East respiratory syndrome (MERS) compared to placebo, according to a study published in the New England Journal of Medicine. Treatment was most successful when started within the first 7 days of symptom onset. In this a...